These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Functional properties of thrombocytes and inhibitors of proteolytic enzymes of the blood in patients with acute forms of ischemic heart disease]. Kakuliia MSh; Panchenko VM Kardiologiia; 1988 May; 28(5):42-6. PubMed ID: 2457730 [TBL] [Abstract][Full Text] [Related]
7. Studies on plasma inhibitors of plasma kallikrein using chromogenic peptide substrate assays. Gallimore MJ; Amundsen E; Larsbraaten M; Lyngaas K; Fareid E Thromb Res; 1979; 16(5-6):695-703. PubMed ID: 93313 [No Abstract] [Full Text] [Related]
8. [Age characteristics of the changes in the blood coagulation and anticoagulation system in patients with acute coronary insufficiency]. Sakharchuk II; Parkhotik II Kardiologiia; 1970 Oct; 10(10):20-6. PubMed ID: 5504111 [No Abstract] [Full Text] [Related]
9. Inhibition of human factor Xa by various plasma protease inhibitors. Ellis V; Scully M; MacGregor I; Kakkar V Biochim Biophys Acta; 1982 Feb; 701(1):24-31. PubMed ID: 6173074 [TBL] [Abstract][Full Text] [Related]
10. [Behavior of some blood coagulation parameters in angiographically documented coronary arteriosclerosis]. Panizza P; Majolino I; Nalli G; Mussini A Haematologica; 1981 Dec; 66(6):768-78. PubMed ID: 6175552 [No Abstract] [Full Text] [Related]
11. Blood coagulability and lipid metabolism in patients with coronary insufficiency. Panchenko VM; Bazaz'yan GG Fed Proc Transl Suppl; 1966; 25(5):800-2. PubMed ID: 5223562 [No Abstract] [Full Text] [Related]
12. Evaluation of factors predisposing to arterial thrombosis in coronary artery disease. Saxena R; Talwar KK; Kotte VK; Rao YV; Salam SR; Saraya AK Indian Heart J; 1990; 42(6):433-5. PubMed ID: 1711506 [TBL] [Abstract][Full Text] [Related]
14. Functional and antigenic antithrombin III in angina pectoris and acute myocardial infarction patients. Vonica A; Văgăonescu T; Cristea A; Stăncioiu N Med Interne; 1990; 28(4):311-7. PubMed ID: 2100876 [TBL] [Abstract][Full Text] [Related]
15. [Relationship between the incidence of acute myocardial infarct, myocardial ischemia and angina and various phenotypes of ABO blood groups]. Galeazzi L; Gualandri V G Ital Cardiol; 1972; 2(5):727-33. PubMed ID: 5079027 [No Abstract] [Full Text] [Related]
16. [Blood coagulation in coronary artery disease (author's transl)]. Aosaki M; Hirosawa K Kokyu To Junkan; 1976 Oct; 24(10):855-64. PubMed ID: 1033595 [No Abstract] [Full Text] [Related]
17. Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation. Fischer AM; Tapon-Bretaudiere J; Bros A; Josso F Thromb Haemost; 1981 Feb; 45(1):51-4. PubMed ID: 6166063 [TBL] [Abstract][Full Text] [Related]
18. Serum protease inhibitors promote anchorage-independent growth of transformed cells in serum-free medium. Chen JK Life Sci; 1992; 51(5):375-80. PubMed ID: 1378169 [TBL] [Abstract][Full Text] [Related]
20. [Prothrombin activity of the blood and tolerance of the plasma to heparin in stenocardia and myocardial infarct]. MALIAROVSKII VN Ter Arkh; 1960 Mar; 32():73-5. PubMed ID: 14420304 [No Abstract] [Full Text] [Related] [Next] [New Search]